125 related articles for article (PubMed ID: 11892286)
1. Familial hypertrophic cardiomyopathic myosin mutations that affect the actin-myosin interaction.
Roopnarine O
Results Probl Cell Differ; 2002; 36():75-86. PubMed ID: 11892286
[No Abstract] [Full Text] [Related]
2. Insights into actomyosin interactions from actin mutations.
Doyle TC; Reisler E
Results Probl Cell Differ; 2002; 36():31-49. PubMed ID: 11892282
[No Abstract] [Full Text] [Related]
3. Cardiomyopathy-linked myosin regulatory light chain mutations disrupt myosin strain-dependent biochemistry.
Greenberg MJ; Kazmierczak K; Szczesna-Cordary D; Moore JR
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17403-8. PubMed ID: 20855589
[TBL] [Abstract][Full Text] [Related]
4. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence resonance energy transfer in acto-myosin complexes.
Yengo CM; Berger CL
Results Probl Cell Differ; 2002; 36():21-30. PubMed ID: 11892281
[No Abstract] [Full Text] [Related]
6. Cooperativity in the Ca2+ regulation of muscle contraction.
Geeves MA; Lehrer SS
Results Probl Cell Differ; 2002; 36():111-32. PubMed ID: 11892276
[No Abstract] [Full Text] [Related]
7. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation.
D'Amico A; Graziano C; Pacileo G; Petrini S; Nowak KJ; Boldrini R; Jacques A; Feng JJ; Porfirio B; Sewry CA; Santorelli FM; Limongelli G; Bertini E; Laing N; Marston SB
Neuromuscul Disord; 2006 Oct; 16(9-10):548-52. PubMed ID: 16945537
[TBL] [Abstract][Full Text] [Related]
8. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
[TBL] [Abstract][Full Text] [Related]
9. Do the FHC-associated R403 mutations in myosin heavy chain lead to a greater energetic cost of contraction?
Ingwall JS
J Mol Cell Cardiol; 2004 Mar; 36(3):327-30. PubMed ID: 15010270
[No Abstract] [Full Text] [Related]
10. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
[TBL] [Abstract][Full Text] [Related]
11. The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
Eldin P; Le Cunff M; Mornet D; Leger JJ
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):345-51. PubMed ID: 7887887
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
[TBL] [Abstract][Full Text] [Related]
13. Myosin cross-bridges do not form precise rigor bonds in hypertrophic heart muscle carrying troponin T mutations.
Midde K; Dumka V; Pinto JR; Muthu P; Marandos P; Gryczynski I; Gryczynski Z; Potter JD; Borejdo J
J Mol Cell Cardiol; 2011 Sep; 51(3):409-18. PubMed ID: 21683708
[TBL] [Abstract][Full Text] [Related]
14. The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q.
Robertson IM; Sevrieva I; Li MX; Irving M; Sun YB; Sykes BD
J Mol Cell Cardiol; 2015 Oct; 87():257-69. PubMed ID: 26341255
[TBL] [Abstract][Full Text] [Related]
15. Coupling between chemical and mechanical events and conformation of single protein molecules.
Ishii Y; Ishijima A; Yanagid T
Results Probl Cell Differ; 2002; 36():87-105. PubMed ID: 11892287
[No Abstract] [Full Text] [Related]
16. Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains.
Yampolskaya DS; Kopylova GV; Shchepkin DV; Bershitsky SY; Matyushenko AM; Levitsky DI
Biochemistry (Mosc); 2022 Nov; 87(11):1260-1267. PubMed ID: 36509720
[TBL] [Abstract][Full Text] [Related]
17. Role of charges in actomyosin interactions.
Chaussepied P; Van Dijk J
Results Probl Cell Differ; 2002; 36():51-64. PubMed ID: 11892283
[No Abstract] [Full Text] [Related]
18. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
[TBL] [Abstract][Full Text] [Related]
19. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.
Sweeney HL; Straceski AJ; Leinwand LA; Tikunov BA; Faust L
J Biol Chem; 1994 Jan; 269(3):1603-5. PubMed ID: 8294404
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
